A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

Clinical trial NCT05192356 · COMPLETED

Trial details

NCT number: NCT05192356
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension and Dyslipidemia

Start date: 2022-02-23
Primary completion: 2022-05-08
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.